A urine-concentrating defect in 11β-hydroxysteroid dehydrogenase type 2 null mice

American Journal of Physiology - Renal Physiology

Volumn 303, Issue 4, 2012, Pages

  Evans, Louise C ^a   Livingstone, Dawn E ^a   Kenyon, Christopher J ^a   Jansen, Maurits A ^a   Dear, James W ^a   Mullins, John J ^a   Bailey, Matthew A ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Aldosterone; Aquaporin 2; Corticosterone; Polydipsia; Polyuria; Prenatal programming

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 2; AQUAPORIN 2; AQUAPORIN 3; AQUAPORIN 4; ARGIPRESSIN RECEPTOR; BUMETANIDE; CASPASE 3; DESMOPRESSIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; MINERALOCORTICOID RECEPTOR; PEPTIDYLPROLYL ISOMERASE; RNA 18S; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; TATA BINDING PROTEIN; TRANSCRIPTION FACTOR NFAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES INSIPIDUS; DISEASE COURSE; DOWN REGULATION; GENE EXPRESSION; KIDNEY CONCENTRATING CAPACITY; KIDNEY MEDULLA; KIDNEY STRUCTURE; MOUSE; NATRIURESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYDIPSIA; POLYURIA; PRIORITY JOURNAL; URINE FLOW RATE; WATER DEPRIVATION; WATER METABOLISM;

EID: 84865136523     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00165.2012     Document Type: Article

References (49)

1. Amlal H, Wang Z, Soleimani M. Potassium depletion downregulates chloride-absorbing transporters in rat kidney. J Clin Invest 101: 1045-1054, 1998.
2. Aoyagi T, Koshimizu TA, Tanoue A. Vasopressin regulation of blood pressure and volume: findings from V1a receptor-deficient mice. Kidney Int 76: 1035-1039, 2009.
3. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237: 268-275, 1987.
4. Bailey MA, Craigie E, Livingstone DE, Kotelevtsev YV, Al-Dujaili EA, Kenyon CJ, Mullins JJ. Hsd11b2 haploinsufficiency in mice causes salt sensitivity of blood pressure. Hypertension 57: 515-520, 2011.
5. Bailey MA, Mullins JJ, Kenyon CJ. Mineralocorticoid and glucocorticoid receptors stimulate epithelial sodium channel activity in a mouse model of Cushing syndrome. Hypertension 54: 890-896, 2009.
6. Bailey MA, Paterson JM, Hadoke PW, Wrobel N, Bellamy CO, Brownstein DG, Seckl JR, Mullins JJ. A switch in the mechanism of hypertension in the syndrome of apparent mineralocorticoid excess. J Am Soc Nephrol 19: 47-58, 2008.
7. Bailey MA, Unwin RJ, Shirley DG. In vivo inhibition of renal 11betahydroxysteroid dehydrogenase in the rat stimulates collecting duct sodium reabsorption. Clin Sci (Lond) 101: 195-198, 2001.
8. Bankir L. Antidiuretic action of vasopressin: quantitative aspects and interaction between V1a and V2 receptor-mediated effects. Cardiovasc Res 51: 372-390, 2001.
9. Beck FX, Muller E, Fraek ML, Dorge A, Thurau K. Inner-medullary organic osmolytes and inorganic electrolytes in K depletion. Pflügers Arch 439: 471-476, 2000.
10. +-depleted rat kidney. Am J Physiol 231: 1204-1208, 1976.
11. Biller KJ, Unwin RJ, Shirley DG. Distal tubular electrolyte transport during inhibition of renal 11β-hydroxysteroid dehydrogenase. Am J Physiol Renal Physiol 280: F172-F179, 2001.
12. Brem AS, Morris DJ, Ge Y, Dworkin LD, Tolbert E, Gong R. Direct fibrogenic effects of aldosterone on normotensive kidney: an effect modified by 11β-HSD activity. Am J Physiol Renal Physiol 298: F1178-F1187, 2010.
13. Dagan A, Kwon HM, Dwarakanath V, Baum M. Effect of renal denervation on prenatal programming of hypertension and renal tubular transporter abundance. Am J Physiol Renal Physiol 295: F29-F34, 2008.
14. de Seigneux S, Nielsen J, Olesen ET, Dimke H, Kwon TH, Frøkiær J, Nielsen S. Long-term aldosterone treatment induces decreased apical but increased basolateral expression of AQP2 in CCD of rat kidney. Am J Physiol Renal Physiol 293: F87-F99, 2007.
15. Dear JW, Kobayashi H, Jo SK, Holly MK, Hu X, Yuen PS, Brechbiel MW, Star RA. Dendrimer-enhanced MRI as a diagnostic and prognostic biomarker of sepsis-induced acute renal failure in aged mice. Kidney Int 67: 2159-2167, 2005.
16. Edwards CR, Stewart PM, Burt D, Brett L, McIntyre MA, Sutanto WS, de Kloet ER, Monder C. Localisation of 11 beta-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet 2: 986-989, 1988.
17. Fan YY, Kohno M, Hitomi H, Kitada K, Fujisawa Y, Yatabe J, Yatabe M, Felder RA, Ohsaki H, Rafiq K, Sherajee SJ, Noma T, Nishiyama A, Nakano D. Aldosterone/mineralocorticoid receptor stimulation induces cellular senescence in the kidney. Endocrinology 152: 680-688, 2011.
18. Farese RV Jr, Biglieri EG, Shackleton CH, Irony I, and Gomez-Fontes R. Licorice-induced hypermineralocorticoidism. N Engl J Med 325: 1223-1227, 1991.
19. Fenton RA, Chou CL, Stewart GS, Smith CP, Knepper MA. Urinary concentrating defect in mice with selective deletion of phloretin-sensitive urea transporters in the renal collecting duct. Proc Natl Acad Sci USA 101: 7469-7474, 2004.
20. Fenton RA, Smith CP, Knepper MA. Role of collecting duct urea transporters in the kidney-insights from mouse models. J Membr Biol 212: 119-131, 2006.
21. Funder JW, Pearce PT, Smith R, Smith AI. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242: 583-585, 1988.
22. Gaeggeler HP, Gonzalez-Rodriguez E, Jaeger NF, Loffing-Cueni D, Norregaard R, Loffing J, Horisberger JD, Rossier BC. Mineralocorticoid versus glucocorticoid receptor occupancy mediating aldosteronestimulated sodium transport in a novel renal cell line. J Am Soc Nephrol 16: 878-891, 2005.
23. Gertner RA, Klein JD, Bailey JL, Kim DU, Luo XH, Bagnasco SM, Sands JM. Aldosterone decreases UT-A1 urea transporter expression via the mineralocorticoid receptor. J Am Soc Nephrol 15: 558-565, 2004.
24. Gomez-Sanchez EP, Gomez-Sanchez CE. Central hypertensinogenic effects of glycyrrhizic acid and carbenoxolone. Am J Physiol Endocrinol Metab 263: E1125-E1130, 1992.
25. Guo JK, Marlier A, Shi H, Shan A, Ardito TA, Du ZP, Kashgarian M, Krause DS, Biemesderfer D, Cantley LG. Increased tubular proliferation as an adaptive response to glomerular albuminuria. J Am Soc Nephrol 23: 429-437, 2011.
26. Holmes MC, Abrahamsen CT, French KL, Paterson JM, Mullins JJ, Seckl JR. The mother or the fetus? 11Beta-hydroxysteroid dehydrogenase type 2 null mice provide evidence for direct fetal programming of behavior by endogenous glucocorticoids. J Neurosci 26: 3840-3844, 2006.
27. Holmes MC, Seckl JR. The role of 11beta-hydroxysteroid dehydrogenases in the brain. Mol Cell Endocrinol 248: 9-14, 2006.
28. Jeon US, Han KH, Park SH, Lee SD, Sheen MR, Jung JY, Kim WY, Sands JM, Kim J, Kwon HM. Downregulation of renal TonEBP in hypokalemic rats. Am J Physiol Renal Physiol 293: F408-F415, 2007.
29. Jonassen TE, Promeneur D, Christensen S, Petersen JS, Nielsen S. Decreased vasopressin-mediated renal water reabsorption in rats with chronic aldosterone-receptor blockade. Am J Physiol Renal Physiol 278: F246-F256, 2000.
30. Jung JY, Madsen KM, Han KH, Yang CW, Knepper MA, Sands JM, Kim J. Expression of urea transporters in potassium-depleted mouse kidney. Am J Physiol Renal Physiol 285: F1210-F1224, 2003.
31. Knepper MA, Danielson RA, Saidel GM, Johnston KH. Effects of dietary protein restriction and glucocorticoid administration on urea excretion in rats. Kidney Int 8: 303-315, 1975.
32. Knox FG, Burnett JC Jr, Kohan DE, Spielman WS, Strand JC. Escape from the sodium-retaining effects of mineralocorticoids. Kidney Int 17: 263-276, 1980.
33. Kotelevtsev Y, Brown RW, Fleming S, Kenyon C, Edwards CR, Seckl JR, Mullins JJ. Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2. J Clin Invest 103: 683-689, 1999.
34. Levinsky NG, Berliner RW. The role of urea in the urine concentrating mechanism. J Clin Invest 38: 741-748, 1959.
35. Lopez-Rodriguez C, Antos CL, Shelton JM, Richardson JA, Lin F, Novobrantseva TI, Bronson RT, Igarashi P, Rao A, Olson EN. Loss of NFAT5 results in renal atrophy and lack of tonicity-responsive gene expression. Proc Natl Acad Sci USA 101: 2392-2397, 2004.
36. Marples D, Frokiaer J, Dorup J, Knepper MA, Nielsen S. Hypokalemia-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla and cortex. J Clin Invest 97: 1960-1968, 1996.
37. Naruse M, Klein JD, Ashkar ZM, Jacobs JD, Sands JM. Glucocorticoids downregulate the vasopressin-regulated urea transporter in rat terminal inner medullary collecting ducts. J Am Soc Nephrol 8: 517-523, 1997.
38. New MI, Wilson RC. Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess. Proc Natl Acad Sci USA 96: 12790-12797, 1999.
39. Nielsen S, Frokiaer J, Marples D, Kwon TH, Agre P, Knepper MA. Aquaporins in the kidney: from molecules to medicine. Physiol Rev 82: 205-244, 2002.
40. Oppermann M, Hansen PB, Castrop H, Schnermann J. Vasodilatation of afferent arterioles and paradoxical increase of renal vascular resistance by furosemide in mice. Am J Physiol Renal Physiol 293: F279-F287, 2007.
41. Ortiz LA, Quan A, Weinberg A, Baum M. Effect of prenatal dexamethasone on rat renal development. Kidney Int 59: 1663-1669, 2001.
42. Peng T, Sands JM, Bagnasco SM. Glucocorticoids inhibit transcription and expression of the UT-A urea transporter gene. Am J Physiol Renal Physiol 282: F853-F858, 2002.
43. Rafiq K, Nakano D, Ihara G, Hitomi H, Fujisawa Y, Ohashi N, Kobori H, Nagai Y, Kiyomoto H, Kohno M, Nishiyama A. Effects of mineralocorticoid receptor blockade on glucocorticoid-induced renal injury in adrenalectomized rats. J Hypertens 29: 290-298, 2011.
44. Rane S, Aperia A, Eneroth P, Lundin S. Development of urinary concentrating capacity in weaning rats. Pediatr Res 19: 472-475, 1985.
45. Raymond KH, Lifschitz MD, McKinney TD. Prostaglandins and the urinary concentrating defect in potassium-depleted rabbits. Am J Physiol Renal Fluid Electrolyte Physiol 253: F1113-F1119, 1987.
46. Sands JM. Mammalian urea transporters. Annu Rev Physiol 65: 543-566, 2003.
47. Stewart PM, Corrie JE, Shackleton CH, Edwards CR. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle. J Clin Invest 82: 340-349, 1988.
48. Stubbe J, Madsen K, Nielsen FT, Skott O, Jensen BL. Glucocorticoid impairs growth of kidney outer medulla and accelerates loop of Henle differentiation and urinary concentrating capacity in rat kidney development. Am J Physiol Renal Physiol 291: F812-F822, 2006.
49. Wang XY, Beutler K, Nielsen J, Nielsen S, Knepper MA, Masilamani S. Decreased abundance of collecting duct urea transporters UT-A1 and UT-A3 with ECF volume expansion. Am J Physiol Renal Physiol 282: F577-F584, 2002.